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e.2013.01Abstract Background: In order to reduce the probability of later clinical involvement of the axilla
and at establishing a sound basis for adjuvant treatment planning axillary dissection is an important
operative procedure. So, partial axillary dissection has been applied to decrease the morbidity and
postoperative axillary complications.
Aim of the work was to study the reliability of partial axillary lymph node dissection in patients
with breast carcinoma with clinically negative axilla.
Methods: Eighteen patients underwent modiﬁed radical mastectomy, while the other two patients
who were fulﬁlling the criteria for conservative breast surgery underwent lumpectomy. All patients
did complete axillary lymph nodes dissection. Intraoperative leveling of the axilla was performed
and level I axillary lymph nodes were identiﬁed according to their relation to pectoralis minor mus-
cle; then they were subjected to intraoperative pathological examination by frozen section examina-
tion followed by complete axillary clearance. Then post operative histopathological examination of
the tumor and all lymph nodes was done.
Results: By intraoperative pathological examination; ﬁve patients (25%) were found positive for
malignant invasion, while 15 patients (75%) were pathologically free. While parafﬁn section showed
six patients (30%)withmalignant invasion, and 14 patients (70%)were pathologically free. There was
a false negative rate of 5% in level I axillary lymph nodes by intraoperative pathological examination
which was positive for metastasis by parafﬁn section that revealed microinvasion in one lymph node
out of 8 in level I. Only two cases out of 20 were found positive for metastasis in level II and III.
Conclusion: Partial axillary lymph node dissection is a minimally invasive, feasible and sufﬁcient
technique that can predict the axillary lymph node status.
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.0011. Introduction
The trend toward less radical breast surgery was attributable
to two important factors. Firstly, surgeons during the latter
half of the 20th century were seeing patients with smaller
tumors, and these were often amenable to local excision. Sec-
ondarily, there were improvements in radiotherapy (RT) tech-
niques, enabling tumoricidal doses to be delivered effectivelylexandria University Faculty of Medicine.
Figure 1 Intraoperative leveling of level I axillary lymph node in
order to perform partial axillary dissection to be sent for frozen
section before the completion of axillary clearance as a part of
modiﬁed radical mastectomy in a female patient with early breast
cancer.
Figure 2 Showing axillary dissection as a part of modiﬁed
radical mastectomy in a case of early breast cancer with
identiﬁcation of the axillary vein.
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surgeons developed an interest in breast-conserving surgery
(BCS), undertaken in conjunction with breast RT. Surgical
management of the axilla in breast cancer patients has been
a subject of intense debate and controversy. The main prog-
nostic predictor of survival in breast cancer is the axillary no-
dal involvement as regards the number and level of nodes in
relation to pectoralis minor muscle. If there is axillary involve-
ment, the 10-year disease-free survival rate is close to 70–80%,
which falls to 35–40% with one to three positive nodes and 10–
15% in the presence of more than 10 positive nodes.1,2
Standard policy for management of the axilla is complete
axillary dissection with removal of axillary lymph nodes below
the axillary vein including levels I and II as in partial axillary
dissection as well as level III dissection which involves the
complete removal of all nodal tissues located medial to or
above the upper border of pectoralis minor. The dissection ex-
tends superomedially to the lateral border of the ﬁrst rib and
costoclavicular (Halsted’s) ligament, including the subclavicu-
lar group.3
This leads to axillary complications such as seroma which is
the commonest postoperative complication after axillary clear-
ance in which different causes have been involved but interrup-
tion of axillary lymphatics is highly responsible of all,4,5 Petrek
et al.,6 found that the more the axillary dissection the more lia-
bility to seroma occurrence. Some authors consider seroma as
‘‘necessary evil’’ that occurs unpredictably.4,5
Also, lymphedema of the arm may lead to functional and
psychological disability and may lead to the development of
cellulites and repeated infection of the upper arm.7,8 Dull ach-
ing pain and paresthesia are due to intercostalbrachial nerve
injury. This may remain for a long postoperative period and
may be improved by conservative treatment and physiother-
apy.9 Rarely, motor injury may occur due to the thoracodor-
sal, long thoracic or pectoral nerves involvement and if it
happens it is treated also by conservation and physiotherapy.10
Aim of the work was to study the reliability of partial axil-
lary lymph node dissection in patients with breast carcinoma
with clinically negative axilla for avoidance of postoperative
complications induced from unnecessary complete axillary
dissection.2. Patients and methods
The study included 20 female patients suffering from early
breast cancer (stages I and II) with clinically negative axilla.
After informed patient consent, 18 patients underwent modi-
ﬁed radical mastectomy, while the other two patients who were
fulﬁlling the criteria for conservative breast surgery underwent
lumpectomy. All patients did complete axillary lymph node dis-
section. Intraoperative leveling of the axilla was performed and
level I axillary lymph nodes were identiﬁed according to their
relation to pectoralis minor muscle; then they were subjected
to intraoperative pathological examination by frozen section
examination followed by complete axillary clearance. (Figs. 1
and 2) Then post operative histopathological examination of
the tumor and all lymph nodes was done; regarding type, grade
(including nuclear core, differentiation andmitotic index), pres-
ence of necrosis, vascular, lymphatic invasion and tumor typing
are assessed according to WHO classiﬁcation and Bloom and
Richardson system. The results are tabulated and analyzed byThe Statistical Package for the Social Sciences (SPSS) software
version 15 for windows. Qualitative data were analyzed using
Fisher Exact and Monte Carlo tests. Also comparison between
quantitative data was analyzed using Student’s t-test and F-test.
3. Results
Eighteen patients were operated upon by modiﬁed radical mas-
tectomy while only two patients were operated upon by breast
conservative surgery. Histopathological type of the tumor re-
vealed invasive ductal carcinoma not otherwise speciﬁed
(NOS) in 16 patients, and invasive ductal carcinoma with pre-
dominant comedo component in four patients. According to
Scarff, Bloom and Richardson classiﬁcation; two patients
(15%) were grade I, 14 patients (65%) were grade II, and four
patients (20%) were grade III. Five patients had lympho-vas-
cular and peri-neural invasion around the tumor and in 15 pa-
tients, the tumor was not associated with lympho-vascular
invasion.
The mean number of dissected LN was 4.7 ± 2.5 ranging
from 1 to 12 lymph nodes. In six patients (30%), level I was
Table 2 Relationship between tumor size, pathological type,
grading and axillary lymph node status after parafﬁn section.
Tumor size LN metastasis Total
Yes No
(T1) 1 6 7
(T2) 5 8 13
Total 6 14 20
X2(P value) 0.423 (0.0001*)
Pathology of the tumor LN metastasis Total
Yes No
(IDC) 6 10 16
IDC with comedo 0 4 4
Total 6 14 20
X2 (P value) 0.327 (0.143)
Tumor grade LN metastasis Total
Yes No
GI 0 2 2
GII 3 11 14
GIII 3 1 4
Total 6 14 20
X2(P value) 0.324 (0.017)
IDC= invasive ductal carcinoma.
* Signiﬁcant.
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(70%) level I was found negative for malignancy. According
to the pattern of lymph node metastasis in the six cases: two
cases (33.3%) presented as microinvasion (6 2 mm) while four
cases (66.6%) presented as macroinvasion (>2 mm).
Intraoperative pathological examination of level I axillary
LN (Imprint cytology and frozen section) revealed that 15
cases were negative and ﬁve cases were positive for metastasis.
On reviewing these results by parafﬁn section; 14 cases were
negative and six cases were positive for metastasis, this was sig-
niﬁcant Table 1 (X2 = 0.88 P value = 0.001*) only one case
was failed to be detected by intraoperative pathological exam-
ination and was detected by parafﬁn section. This case showed:
micrometastasis (6 2 mm), number of LN involved was only
one out of eight, levels II and III were negative, histopatholo-
gical criteria of the resected tumor were invasive ductal carci-
noma, grade III with lymphovascular invasion.
The sensitivity of intra-operative pathological examination
of level I axillary lymph nodes was 83.39%, the accuracy is
95%, the negative predictive value is 93.33%, both the speciﬁc-
ity and positive predictive value were 100%. Levels II and III
axillary LN were positive in only two cases while 18 cases were
negative for metastasis.
So in summary patients were divided according to the re-
sults of intraoperative pathological examination of level I
and parafﬁn section: ﬁrst group was negative intra-operative
pathology with negative parafﬁn section (14 cases). Second
group was positive intra-operative pathology with positive
parafﬁn section (ﬁve cases). Third group was negative intra-
operative pathology with positive parafﬁn section (One case).
The relation between intra-operative pathological examina-
tion of level I axillary LN and parafﬁn section of levels II and
III LNs was: 15 cases which were negative for level I were also
negative for levels II and III. While out of the ﬁve positive cases
for level one only two were positive for level II and III and this
was signiﬁcant. Table 1 (X2 = 0.509, p= 0.012*). The two
cases that showed metastasis in levels II and III were as follows:
ﬁrst case; inﬁltrating ductal carcinoma grade III, with four inﬁl-
trated nodes in level I and II inﬁltrated nodes out of nine in lev-
els II and III. The other case was inﬁltrating ductal carcinomaTable 1 Relationship between lymphovascular invasion of the
tumor, intra-operative pathological examination of level I
axillary LN, and axillary lymph node status.
Lympho-vascular
invasion
Lymph node metastasis Total
Yes No
Yes 5 0 5
No 1 14 15
Total 6 14 20
X2 (P value) 0.88 (0.0001*)
Intra-operative
pathology
of level I LN
Pathology of LN in level II and III Total
Positive Negative
Positive 2 3 5
Negative 0 15 15
Total 2 18 20
X2 (P value) 0.509 (0.012*)
* Signiﬁcant.grade II, with one inﬁltrated node out of six in level I and one
positive out of 12 in levels II and III.
The relation between axillary lymph node metastasis and
pathological features of the primary tumor: lymph node metas-
tasis was frequently associated with bigger sized tumors. Five
patients out of 13 presented with T2 tumor; (the minimum size
was 2.5 cm and the maximum was 5 cm with a mean of 3.7 cm)
had lymph node metastasis and 1 out of 7 patients who pre-
sented with T1 tumor had lymph node metastasis. This relation
was statistically signiﬁcant Table 2 (X2 = 0.423, p< 0.0001).
Six patients out of 16 with invasive ductal carcinoma IDC
(NOS) had axillary lymph node metastases. None of the
remaining four cases with IDC predominant comedo compo-
nent type had axillary lymph node metastases. This relation
was statistically insigniﬁcant Table 2 (X2 = 0.327, p< 0.143).
No lymph node metastasis was encountered in two patients
having grade I, while 3 patients out of 13 with grade II had
LN metastasis and 3 patients out of 5 with grade III had LN
metastasis. This relation was statistically insigniﬁcant Table 2
(X2 = 0.324, p < 0.017). Patients with lympho-vascular inva-
sion were more likely to have lymph node metastasis. All pa-
tients with lympho-vascular invasion had positive axillary
lymph node metastasis, while only 1 patient out of 15 with ab-
sent lympho-vascular invasion had positive lymph node metas-
tasis on histopathological examination and this relation was
statistically signiﬁcant Table 1 (X2 = 0.88, p< 0.0001).
4. Discussion
As a part of breast cancer surgery complete axillary dissection
can result in several complications such as lymph-edema;
which is a bad complication that produces upper limb handi-
capness and manifests itself very late, also other complications
including nerve injury, shoulder dysfunction, resistant seroma
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life; this has led to the development of limited axillary dissec-
tion techniques. Although there is a general agreement that
for larger tumors and clinically involved nodes, conventional
axillary dissection is recommended, in T1 and T2 lesion with-
out clinical disease in the axilla, the extent of surgery is
controversial.11
This study was conducted on 20 female patients with T1
and T2 with clinically non palpable axillary lymph nodes.
These patients underwent dissection of level I axillary lymph
nodes before proceeding to complete axillary clearance and
this level was subjected to intraoperative pathological exami-
nation in the form of imprint cytology and frozen section,
and after that it was submitted to ordinary histopathological
examination.12,13
Chen et al.14 had studied some of the tumor characteristics
in an attempt to identify a correlation between them and axil-
lary lymph node metastasis such as histopathological type,
presence or absence of ductal carcinoma in situ (DCIS), com-
edo carcinoma, or lobular carcinoma they did not ﬁnd any sta-
tistically signiﬁcant relations between these features and lymph
node metastasis, they concluded that all of these factors were
equivocal in predicting lymph node metastasis. In our study
the relation between histo-pathological types and axillary
lymph node metastasis was also statistically insigniﬁcant. In
our study there was a statistically signiﬁcant relation between
tumor grading with axillary lymph node metastasis this was
coinciding with the study of Roderick et al.15, but was not
compatible with the results of Ishikawa et al.16 and Rahusen
et al.17 who found a non signiﬁcant relation between the tumor
grade and lymph node metastasis.
Woo et al.18 and Dewar et al.19 found that lympho-vascular
invasion highly correlated with the presence of axillary lymph
node metastasis. In the present study, ﬁve patients (25%) pre-
sented with lympho-vascular invasion around primary tumor,
all of them had axillary lymph node metastasis while among
the other 15 patients who presented without lympho-vascular
invasion only one case of them had lymph node metastasis.
Veronesi et al.20 studied 539 node positive cases in which
they did complete axillary dissection; 98.5% had metastases
in level I nodes. Level I was skipped by metastases in eight pa-
tients, while both lower levels (I, II) were skipped in only two
patients. In another study they found seven of 80 node-positive
patients had metastases that skipped level (I) but were observed
in other levels II and III. The positive predictive value of a level
(I) axillary dissection is actually higher than 91.3% because
over half of axillary dissections (60% in their series) prove to
have no nodal involvement and hence would have been pre-
dicted correctly by the examination of only level (I) nodes.19–21
Other investigators have studied axillary lymphadenec-
tomy of a lesser scope than a formal level (I) dissection. Only
level (I) dissection was noted to be accurate for qualitative
analysis in one randomized study from the Scottish Cancer
Trials. In 417 randomized patients, similar rates of node po-
sitive were found with limited level (I) dissection and with
complete levels (I) and (II) nodal clearance. A mean of four
axillary nodes was found in limited level (I) axillary dissec-
tion specimens. There was a similarity in rates of node posi-
tive noted between level I dissection and the complete
dissection. Each of the 16 patients who underwent both level
I and complete axillary dissection was correctly recognized
by the limited dissection data. Only one patient in the entireseries failed to have lymph nodes identiﬁed in the limited dis-
section specimen.22
However, the diagnostic accuracy of limited level (I) axillary
dissection critically depends on the surgical technique. Also a
study from the Scottish data, found no nodes to be identiﬁed
in 116 (25%) of 473 patients with early breast cancer treated
by level (I) axillary dissection. Others found a qualitative error
for nodal sampling in 18% of 50 mastectomies in which preop-
erative sampling preceded axillary node clearance.23,24
In the current study 20 patients with clinically negative
nodes were treated by complete axillary clearance (Levels I,
II and III); there were six patients (30%) showing metastasis
to axillary lymph node, 100% of these metastasis (six cases)
were found in level (I) axillary lymph nodes with no skip
metastasis to other levels II and III. Four cases of them
(66.6%) showed metastases to level (I) LNs only, while two
cases (33.3%) showed metastases to level II and III in addition
to level I as all patients underwent level I axillary dissection
followed by completeness of the axilla .
The study of Bonn Chua et al.25 showed level (I) was posi-
tive in 45% of cases, 78% of these cases had metastasis in only
level (I) nodes while both level II and III in addition to level (I)
nodes were positive in 21% of cases, skip metastasis were 0.6
of cases. This denotes the necessity to do complete axillary
lymph node dissection if level (I) axillary LNs were found po-
sitive by intraoperative pathological assessment.
As the number and level of axillary nodes are of a signiﬁ-
cant prognostic value; less than three node involvement is of
a better prognosis than more than four node involvement.
Five-year survival proved to be approximately 75% in patients
without lymph node metastases, falling to approximately 60%
in the presence of one to three positive lymph nodes and falling
to 30% or less with four or more metastatic axillary lymph
nodes. Thus, the decreased morbidity of a limited level I dissec-
tion, even if qualitatively accurate, must be weighed against
the information from quantization of metastatic nodes.26
In this study, the sensitivity of intra-operative pathological
examination of level I axillary lymph nodes in detection of
metastasis is 83.39%, the accuracy is 95%, both speciﬁcity
and positive predictive value are 100% while negative predic-
tive value is 93.33%. There were ﬁve cases detected by frozen
section and imprint cytology as positive for metastasis, on
matching these results with parafﬁn section, there was only
one case out of 15 cases that was negative by FS and imprint
cytology but positive by parafﬁn section, hence the false nega-
tive rate was 5%. The study of Van Deist et al.27 observed
combined sensitivity of frozen section and imprint cytology
was 91% in detection of axillary lymph node metastasis as
the frozen section and imprint cytology sensitivity in detection
of micro-metastasis is 27%.
Using standardized method and careful pathologic review,
we found that these methods are highly effective in identifying
macrometastasis and far less effective in ﬁnding micrometasta-
sis; Turner et al.28 found that combination of FS and imprint
cytology identiﬁed only 28% of micrometastasis. In our pa-
tients, only one type of intraoperative assessment would have
been sufﬁcient for detection of macrometastasis because the
sensitivity of frozen section is 96% and 93% for imprint cytol-
ogy. However to detect micrometastatic lesions in examined
LNs both techniques have to be used in combination to rela-
tively improve the diagnostic yield as the sensitivity for detec-
tion of micrometastasis is 27% for each.
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erative assessment of level (I) axillary LNs were encountered for
comparing our results. However the available studies were con-
sidered with studying SLN biopsy. Veronesi et al.29 and Viale et
al.30 have described a method of exhaustive frozen section of
SLN that offers a near perfect sensitivity. It entails a work load
of (60 sections per node, stained with H and E and rapid IHC).
Detailed histopathological work-ups of axillary lymph nodes
using serial or step sectioning and immunohistochemistry
(IHC) increased the rate at which metastatic cells and microme-
tastases are detected and hence less FNR. This has been proved
by examination of multiple permanent sections.31,32
5. Conclusions
Partial axillary lymph node dissection is a minimally invasive,
feasible and sufﬁcient technique that can predict the axillary
lymph node status. Intraoperative pathological examination
of level I axillary lymph node is a reliable procedure in the
assessment of axilla in early breast cancer with clinically non
palpable axillary LNs. Routine intraoperative pathological
examination of axillary lymph nodes can detect metastatic dis-
ease, allowing immediate axillary dissection, if necessary and
avoiding the need for reoperation.
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